• Science and Research

  Vertex Plans to Seek Approval of VX-445 Triple Combo in US and Europe

  Posted by cystic-fibrosis-news-moderator on June 5, 2019 at 7:04 pm

  

  Vertex Pharmaceuticals chose its VX-445 triple regimen to apply for regulatory approvals in the U.S. and Europe for the treatment of CF in those 12 and up. Read more about this decision here.

  What do you think of this news?

  cystic-fibrosis-news-moderator replied 4 years, 10 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply